|Bid||28.55 x 1200|
|Ask||40.55 x 800|
|Day's Range||37.63 - 38.64|
|52 Week Range||22.06 - 49.00|
|Beta (5Y Monthly)||0.94|
|PE Ratio (TTM)||68.46|
|Earnings Date||Aug 05, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||64.25|
Surmodics announced it receives FDA 510(k) Clearance for Pounce™ Thrombus Retrieval System.
Investor confidence is high on Surmodics (SRDX) stock, thanks to solid prospects.
SurModics (SRDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.